Cargando…
Clinical observation of apatinib-related hypothyroidism in patients with advanced malignancies
Thyroid dysfunction has been previously reported during treatment with certain small-molecule multi-tyrosine kinase inhibitors, including sunitinib and sorafenib. Apatinib, which has a similar mechanism of action to these inhibitors, has reportedly induced hypothyroidism during treatment. Fully eluc...
Autores principales: | Xiao, Junjuan, Liang, Jing, Zhang, Wei, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401193/ https://www.ncbi.nlm.nih.gov/pubmed/32782505 http://dx.doi.org/10.3892/etm.2020.8937 |
Ejemplares similares
-
Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma
por: Xie, Lu, et al.
Publicado: (2020) -
Apatinib mesylate tablet in the treatment of advanced malignant melanoma
por: Yang, Lingge, et al.
Publicado: (2018) -
Apatinib for salvage treatment of advanced malignant pleural mesothelioma: A case report
por: Du, Zedong, et al.
Publicado: (2018) -
Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
por: Liu, Guohui, et al.
Publicado: (2019) -
Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report
por: Liang, Lijun, et al.
Publicado: (2017)